FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...